Last reviewed · How we verify
NCT03912103: FMA-CPH
Interdisciplinary Medication Review Interventions in an Integrated Outpatient Department.
NA trial testing Interdisciplinary Deprescribing and Medication Optimization Intervention in Comorbidity in 72 participants. Completed in 5 March 2021.
30 December 2019
Quick facts
| Lead sponsor | Region Hovedstadens Apotek |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 72 |
| Start date | 19 March 2019 |
| Primary completion | 30 December 2019 |
| Estimated completion | 5 March 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Interdisciplinary Deprescribing and Medication Optimization Intervention
Conditions studied
- Comorbidity — all drugs for Comorbidity →
- Multimorbidity — all drugs for Multimorbidity →
- Drug Prescribing — all drugs for Drug Prescribing →
- Cognitive Impairment — all drugs for Cognitive Impairment →
Sponsor
Region Hovedstadens Apotek
Who can join
18 and older, any sex, with Comorbidity or Multimorbidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Inappropriate medication prescribing is highly prevalent among comorbid medical patients and leading to adverse drug events (ADE), re-admissions, quality of life and mortality. Thus, the aim of this study is primary to investigate the feasibility of a interdisciplinary intervention focused on deprescribing and medication optimization in the Integrated Outpatient Department at Copenhagen University Hospital, Amager, Denmark. Participants in the intervention group receives a medication review by a clinical pharmacist and physician with a follow up after 7 and 30 days. The control group receives standard care.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial.
Aharaz A, Rasmussen JH, McNulty HBØ, Cyron A, et al · · 2021 · cited 17× · PMID 33808080 · DOI 10.3390/metabo11040204 -
Patients' Attitudes Towards Deprescribing and Associations With Patient-Related Factors Across Two Hospital Settings.
Christensen LWS, El Gamah I, Barre AOI, Moga DC, et al · · 2026 · PMID 41742348 · DOI 10.1111/bcpt.70215
Verify or expand the search:
- PubMed search for NCT03912103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Comorbidity
Currently open trials in the same condition.
- NCT06968832 — Project COMET: Massed Prolonged Exposure for PTSD and SUD · NA · recruiting
Other Region Hovedstadens Apotek trials
Trials by the same sponsor.
- NCT03829995 — Effect of Pharmacist Provided Drug Information Services After Hospital Discharge · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03912103 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Hovedstadens Apotek
- Last refreshed: 13 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03912103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing